Disparate CD4+ lamina propria (LP) lymphokine secretion profiles in inflammatory bowel disease. Crohn's disease LP cells manifest increased secretion of IFN-gamma, whereas ulcerative colitis LP cells manifest increased secretion of IL-5 - PubMed (original) (raw)
. 1996 Aug 1;157(3):1261-70.
Affiliations
- PMID: 8757634
Disparate CD4+ lamina propria (LP) lymphokine secretion profiles in inflammatory bowel disease. Crohn's disease LP cells manifest increased secretion of IFN-gamma, whereas ulcerative colitis LP cells manifest increased secretion of IL-5
I J Fuss et al. J Immunol. 1996.
Abstract
In this study, we investigate whether human inflammatory bowel disease (IBD) (ulcerative colitis and Crohn's disease) is associated with altered lymphokine secretion profiles, as recently found in various animal models of chronic intestinal inflammation. In initial studies, we determined the proliferative responses of purified lamina propria (LP) CD4+ T cells from patients with IBD under defined conditions of T cell stimulation. We found that IBD LP CD4+ T cells in comparison with control LP CD4+ T cells have diminished TCR/CD3 pathway proliferative responses, whereas CD2/CD28 accessory pathway proliferative responses are relatively preserved. In further studies centering on lymphokine production, we showed that LP T cells from inflamed Crohn's disease mucosa manifest increased IFN-gamma secretion compared with control LP T cells, particularly when stimulated via the CD2/CD28 pathway. Subsequent ELISPOT analysis indicated that this was due to an increased number of IFN-gamma-secreting CD4+ T cells. In contrast, IL-4 and IL-5 production by Crohn's disease LP T cells was decreased compared with that of control LP T cells. Of interest, IL-2 production by Crohn's disease LP T cells was also reduced, as was IL-2 production by peripheral blood T cells. In parallel studies, LP T cells from inflamed ulcerative colitis mucosa stimulated via either the TCR/CD3/CD28 or CD2/CD28 produced increased amounts of IL-5, again when measured either as secreted IL-5 or by ELISPOT analysis. Such increased IL-5 production was not associated with increased IL-4 secretion and, in contrast to Crohn's disease, ulcerative colitis LP T cell production of IL-2 and IFN-gamma was normal. Taken together, these studies provide strong evidence that the immunopathologic process characteristic of the two major forms of IBD is associated with very different cytokine secretion patterns. These different patterns may determine the type of inflammatory process present.
Similar articles
- Hypoproliferative human lamina propria T cells retain the capacity to secrete lymphokines when stimulated via CD2/CD28 pathways.
Boirivant M, Fuss I, Fiocchi C, Klein JS, Strong SA, Strober W. Boirivant M, et al. Proc Assoc Am Physicians. 1996 Jan;108(1):55-67. Proc Assoc Am Physicians. 1996. PMID: 8834065 - Type 1 T-helper cell predominance and interleukin-12 expression in the gut of patients with Crohn's disease.
Parronchi P, Romagnani P, Annunziato F, Sampognaro S, Becchio A, Giannarini L, Maggi E, Pupilli C, Tonelli F, Romagnani S. Parronchi P, et al. Am J Pathol. 1997 Mar;150(3):823-32. Am J Pathol. 1997. PMID: 9060820 Free PMC article. - [Functional status of intestinal t lymphocytes, regulatory mechanisms, and their variations in the course of Crohn disease and ulcerative colitis].
Boirivant M, Marini M, Di Felice G. Boirivant M, et al. Ann Ist Super Sanita. 1999;35(2):283-9. Ann Ist Super Sanita. 1999. PMID: 10645662 Review. Italian. - Immune mechanisms in chronic inflammatory bowel disease.
Braegger CP, MacDonald TT. Braegger CP, et al. Ann Allergy. 1994 Feb;72(2):135-41. Ann Allergy. 1994. PMID: 8109803 Review.
Cited by
- Microbiome- and Host Inflammasome-Targeting Inhibitor Nanoligomers Are Therapeutic in the Murine Colitis Model.
Sharma S, Gilberto VS, Levens CL, Chatterjee A, Kuhn KA, Nagpal P. Sharma S, et al. ACS Pharmacol Transl Sci. 2024 Aug 30;7(9):2677-2693. doi: 10.1021/acsptsci.4c00102. eCollection 2024 Sep 13. ACS Pharmacol Transl Sci. 2024. PMID: 39296260 - HIF-2α-dependent induction of miR-29a restrains TH1 activity during T cell dependent colitis.
Czopik AK, McNamee EN, Vaughn V, Huang X, Bang IH, Clark T, Wang Y, Ruan W, Nguyen T, Masterson JC, Tak E, Frank S, Collins CB, Li H, Rodriguez-Aguayo C, Lopez-Berestein G, Gerich ME, Furuta GT, Yuan X, Sood AK, de Zoeten EF, Eltzschig HK. Czopik AK, et al. Nat Commun. 2024 Sep 14;15(1):8042. doi: 10.1038/s41467-024-52113-y. Nat Commun. 2024. PMID: 39271652 Free PMC article. - "Decoding inflammation: glycoprotein a repetition predominant, microRNA-142-3-p, and metastasis associated lung adenocarcinoma transcript 1: as novel inflammatory biomarkers of inflammatory bowel disease".
Lahimchi MR, Mohammadnia-Afrouzi M, Baharlou R, Haghmorad D, Abedi SH, Arjmandi D, Hosseini M, Yousefi B. Lahimchi MR, et al. Mol Biol Rep. 2024 Apr 10;51(1):500. doi: 10.1007/s11033-024-09475-9. Mol Biol Rep. 2024. PMID: 38598005 - The role of goblet cells in Crohn' s disease.
Wang Z, Shen J. Wang Z, et al. Cell Biosci. 2024 Apr 1;14(1):43. doi: 10.1186/s13578-024-01220-w. Cell Biosci. 2024. PMID: 38561835 Free PMC article. Review. - Approaches, Strategies and Procedures for Identifying Anti-Inflammatory Drug Lead Molecules from Natural Products.
Jamtsho T, Yeshi K, Perry MJ, Loukas A, Wangchuk P. Jamtsho T, et al. Pharmaceuticals (Basel). 2024 Feb 22;17(3):283. doi: 10.3390/ph17030283. Pharmaceuticals (Basel). 2024. PMID: 38543070 Free PMC article. Review.
MeSH terms
Substances
LinkOut - more resources
Other Literature Sources
Medical
Research Materials